CureVac fails in pivotal COVID19 vaccine trial

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=qCOI9jwbEDI

German biotech CureVac NV said on Wednesday its COVID-19 vaccine was only 47% effective in a late-stage trial, missing the study's main goal and throwing in doubt the potential delivery of hundreds of millions of doses to the European Union. https://str.sg/34GN • SUBSCRIBE ➤ http://bit.ly/FollowST • -------------------- • WEBSITE ➤ http://www.straitstimes.com • TWITTER ➤ / straits_times • FACEBOOK ➤ / thestraitstimes • INSTAGRAM ➤ / straits_times • PODCASTS ➤ http://str.sg/stpodcasts • TELEGRAM ➤ https://t.me/straitstimes • The Straits Times, the English flagship daily of SPH, has been serving readers for more than a century. Launched on July 15, 1845, its comprehensive coverage of world news, East Asian news, Southeast Asian news, home news, sports news, financial news and lifestyle updates makes The Straits Times the most-read newspaper in Singapore.

#############################

New on site